Lv6
2005 积分 2021-08-19 加入
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records
9小时前
待确认
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
10个月前
已完结
Paraneoplastic syndromes in hepatocellular carcinoma: a review
1年前
已完结
Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer
1年前
已完结
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
1年前
已完结
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma
1年前
已完结
Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study
1年前
已完结
Monoclonal Gammopathy of Thrombotic/thrombocytopenic Significance
1年前
已完结
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma
1年前
已完结
Cancer drug approvals and setbacks in 2023
1年前
已完结
Mesothelin-Specific CAR T Cells Target Ovarian Cancer
皖公网安备34019202002308
